LAZARD ASSET MANAGEMENT LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$885
-68.1%
77,200
-10.4%
0.00%
-75.0%
Q1 2023$2,775
-98.2%
86,155
+676.2%
0.00%
Q2 2022$153,000
-52.6%
11,099
-33.1%
0.00%
Q1 2022$323,000
-20.8%
16,583
-33.8%
0.00%
Q4 2021$408,000
+2300.0%
25,048
+4131.1%
0.00%
Q2 2021$17,000
-94.7%
592
-94.8%
0.00%
Q1 2021$320,000
-29.8%
11,456
-28.9%
0.00%
-100.0%
Q4 2020$456,00016,1180.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders